Motor, non-motor and cognitive correlates of carotid intima-media thickness in patients with Parkinson’s disease
Objective: To determine the correlation of carotid intima-media thickness (IMT) to motor, non-motor and cognitive scales in patients with Parkinson’s disease (PD). Background: Increased IMT…Cognitive profile of the COPPADIS cohort: Sociodemographic characteristics, lifestyle, neuropsychiatric and non-motor(NM) associated features and potentially treatable variables
Objective: To explore the cross-sectional cognitive characteristics of the COPPADIS cohort and to identify associations between cognitive performance and lifestyle, neuropsychiatric symptoms, NM features and…Activated microglia contribute to MPTP-induced impairment of cardiovascular function
Objective: To investigate the contribution of microglia in MPTP-induced loss of adrenergic neurons and impairment of cardiovascular function. Background: Parkinson’s disease (PD) is a neurodegenerative…An investigation of the relationships between measures of pain, physical activity levels, sleep quality and mood in people with Parkinson’s disease
Objective: This cross-sectional observational study explored the relationships between measures of physical activity, sleep and mood with pain in people with Parkinson’s disease (PD). Background:…Apomorphine improves pulmonary function in parkinsonian patients
Objective: Aim of the study; to investigate if apomorphine might facilitate weaning from mechanical ventilation in parkinsonian patients. Background: Apomorphine is an effective treatment for PD…Odor Identification as a Biomarker of Incident Cognitive Impairment and its Correlation with Neuropathology in the Rush MAP
Objective: Evaluate the neuropathological correlates and prospective incident cognitive and motor changes associated with odor identification (OI) in cognitively normal (CN) subjects. Background: Hyposmia is…Disease progression characterized by motor performance, dopaminergic neurodegeneration and T cell infiltration in the transgenic hm2-α-SYN-39 mouse model of Parkinson´s disease
Objective: To study disease progression in the transgenic (tg) hm2-α-SYN-39 mouse model of Parkinson´s disease (PD) by assessment of motor performance, dopaminergic neurodegeneration and T…Identifying biomarkers to predict disease progression in early stage Parkinson’s disease patients
Objective: To evaluate the sensitivity of instrumented measures of motor dysfunction and candidate serological markers of disease to predict disease progression in de novo Parkinson’s…Minor hallucinations in Parkinson’s disease are associated with increased neurofilament plasma levels and reduced white-matter integrity in the inferior longitudinal fasciculus
Objective: To examine whether patients with Parkinson's disease (PD) and isolated minor hallucinations have increased plasma neurofilament light chain (NfL) levels and/or differences in white…Depression in patients with Parkinson’s disease
Objective: The objective of this study was to correlate PD severity with depression. Background: Depression is the most common psychiatric disorder in patients with PD. In…
- « Previous Page
- 1
- …
- 45
- 46
- 47
- 48
- 49
- …
- 149
- Next Page »